Answers are grounded in this paper and cite their sources.
The purpose of these recommendations is to propose a management strategy for the treatment of migraine. They are aimed at general practitioners, doctors in pain clinics and neurologists. Treatment of migraine requires flexibility and an individualized approach for each patient. The guidelines presented are based on the scientific evidence obtained from clinical trials and the extensive clinical experience of the authors and scientific publications. The current recommendations are an updated guideline covering newly introduced drugs for the treatment of chronic migraine.
No takes yet. Share an insight, caveat, or question.
Stępień et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: